Natural Biocon (India) (BOM:543207) Cyclically Adjusted PS Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543207 Natural Biocon (India) Ltd BOM:543207
53 GF Score
Price ₹3.54
GF Value ₹0.93
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Natural Biocon (India) Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Natural Biocon (India)  (BOM:543207) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Natural Biocon (India) Cyclically Adjusted PS Ratio Related Terms


Natural Biocon (India) Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Natural Biocon (India)'s Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natural Biocon (India) Cyclically Adjusted PS Ratio Chart

Natural Biocon (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.20

Natural Biocon (India) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.20 0.00

BOM:543207 vs LIN, SHW, ECL: Cyclically Adjusted PS Ratio Comparison

For the Specialty Chemicals subindustry, Natural Biocon (India)'s Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natural Biocon (India) Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Natural Biocon (India)'s Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Natural Biocon (India)'s Cyclically Adjusted PS Ratio falls into.


BOM:543207
53GF Score
Natural Biocon (India) Ltd BOM:543207
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Natural Biocon (India) Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Natural Biocon (India)'s Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Natural Biocon (India)'s adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Natural Biocon (India) Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.051 105.961 0.081
201612 0.034 105.196 0.054
201703 0.034 105.196 0.054
201706 0.298 107.109 0.466
201709 0.298 109.021 0.457
201712 0.298 109.404 0.456
201803 0.229 109.786 0.349
201806 0.002 111.317 0.003
201809 0.345 115.142 0.501
201812 0.007 115.142 0.010
201903 -0.009 118.202 -0.013
201906 0.000 120.880 0.000
201909 0.000 123.175 0.000
201912 0.000 126.235 0.000
202003 0.000 124.705 0.000
202006 0.000 127.000 0.000
202009 0.036 130.118 0.046
202012 0.100 130.889 0.128
202103 -0.015 131.771 -0.019
202106 0.050 134.084 0.062
202109 0.127 135.847 0.156
202112 0.038 138.161 0.046
202203 0.201 138.822 0.242
202206 0.079 142.347 0.093
202209 0.311 144.661 0.360
202212 0.333 145.763 0.382
202303 0.326 146.865 0.371
202306 0.238 150.280 0.265
202309 2.850 151.492 3.148
202312 1.967 152.924 2.153
202403 7.147 153.035 7.816
202406 0.911 155.789 0.979
202409 1.872 157.882 1.984
202412 0.519 158.323 0.549
202503 0.528 157.552 0.561
202506 0.601 159.755 0.630
202509 0.000 162.289 0.000
202512 0.000 163.281 0.000
202603 0.376 164.272 0.383
202606 0.000 167.357 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Natural Biocon (India) (BOM:543207) Overvalued in 2026?

Based on GuruFocus' analysis, Natural Biocon (India) stock appears to be overvalued. The current stock price of ₹3.54 is trading 280.6% above its estimated GF Value™ of ₹0.93. GuruFocus considers Natural Biocon (India) to be Significantly Overvalued.

Key valuation signals for BOM:543207:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹0.93 vs. price of ₹3.54 (280.6% above fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the BOM:543207 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Natural Biocon (India) Business Description

Address Iscon Temple Cross Road, S. G. Highway, 1007, Sankalp Iconic, Opposite Vikram Nagar, Ahmedabad, GJ, IND, 380054
Natural Biocon (India) Ltd is engaged in the business of chemicals, natural extracts, and agricultural products. The company manufactures natural food colors. Its revenue stream is retail trading of commodities, which are generated through the sale of chemicals in Ahmedabad and Mumbai. The company generates revenue and operates within India.
53GF Score

Get the complete analysis for BOM:543207

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.54
Price
₹0.93
GF Value